UK study highlights importance of GP data in understanding atrial fibrillation
The common heart condition affects approximately 1.5 million people in the UK
Read More
Tag: British Heart Foundation
Study finds AI reduces underdiagnosis of Black patients with common heart failure
Heart failure with preserved ejection fraction makes up 50% of all UK heart failure cases
Read More
BHF’s HIF funds five heart research projects over £800,000
Cardiovascular diseases currently affect around seven million people in the UK, including coronary heart disease
Read More
BHF awards £35m funding to nine UK universities for cardiovascular disease
Affecting more than 7 million people in the UK, cardiovascular diseases are conditions that affect the heart or circulation
Read More
Four international teams awarded £4.7m to investigate heart and circulatory diseases
These types of conditions are responsible for 25% of all UK deaths and affect 7.6 million people nationally
Read More
People with chest pain more likely to develop heart and circulatory diseases
Around one million adults in the UK visit their GP every year due to chest pain
Read More
BHF data reveals early heart disease deaths rise to highest level
In 2022, over 39,000 people in England died prematurely of cardiovascular conditions
Read More
New data reveals out-of-hospital cardiac survival results remain low in England
In 2022, around 8% of patients survived 30 days after a cardiac arrest
Read More
Heart vests to identify those at high risk of sudden cardiac death
In the UK, heart rhythms affect around two million people and can cause sudden death
Read More
BHF and UKDRI announce first UK centre for vascular dementia research
The centre will help discover new treatments to prevent, halt and cure the condition
Read More
Researchers find PCSK9 inhibitors could treat abdominal aortic aneurysms
The condition is responsible for 2,200 annual deaths in the UK
Read More
Study reveals diagnosis and treatment inequalities in NHS heart care
Researchers focused on four of the most common heart conditions in the UK
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
